By Paul McClureJuly 02, 2024 A novel combination treatment for advanced prostate cancer has been granted Fast Track status by the FDADepositphotos The US Food and Drug Administration (FDA) has green-lit the fast-tracking of an innovative personalized treatment for advanced prostate cancer following a promising clinical trial where the cancer disappeared completely in almost 40%...